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Abstract 
AIM 
To analyses the current literature regarding the urogenital functional outcomes of 
patients receiving robotic rectal cancer surgery.  
 
METHODS 
A comprehensive literature search of electronic databases was performed in October 
2015. The following search terms were applied: “rectal cancer” OR “colorectal 
cancer” AND robot* OR “da Vinci” AND sexual OR urolog* OR urinary OR erect* 
OR ejaculat* OR impot* OR incontinence. All original studies examining the 
urological and/or sexual outcomes of male and/or female patients receiving robotic 
rectal cancer surgery were included. Reference lists of all retrieved articles were 
manually searched for further relevant articles. Abstracts were independently 
searched by two authors.  
 
RESULTS 
Fifteen original studies fulfilled the inclusion criteria. A total of 1338 patients were 
included; 818 received robotic, 498 laparoscopic and 22 open rectal cancer surgery. 
Only 726 (54%) patients had their urogenital function assessed via means of 
validated functional questionnaires. From the included studies, three found that 
robotic rectal cancer surgery leads to quicker recovery of male urological function 
and five of male sexual function as compared to laparoscopic surgery. It is unclear 
whether robotic surgery offers favourable urogenital outcomes in the long run for 
males. In female patients only two studies assessed urological and three sexual 
function independently to that of males. In these studies there was no difference 
identified between patients receiving robotic and laparoscopic rectal cancer surgery. 
However, in females the presented evidence was very limited making it impossible 
to draw any substantial conclusions.  
 
CONCLUSION 
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There seems to be a trend towards earlier recovery of male urogenital function 
following robotic surgery. To evaluate this further, larger well designed studies are 
required.  
 
Key words: Rectal neoplasms; Robotic surgical procedures; Colorectal surgery; 
Sexual dysfunction; Physiological; Urinary bladder; Neurogenic; Humans 
 
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights 
reserved. 
 
Core tip: Urogenital dysfunction is a significant problem following rectal cancer 
surgery that significantly affects quality of life. Despite laparoscopic total mesorectal 
excision becoming the standard approach in much of the developed world, the 
incidence of post-operative urogenital dysfunction remains high. Robotic surgery 
allows for precision surgery in the pelvis, therefore enabling better preservation of 
the pelvic autonomic nerves. Current studies examining the urogenital outcomes 
following robotic rectal cancer surgery have several limitations, but suggest that 
robotic surgery may offer favourable outcomes when compared to laparoscopic and 
open surgery. Larger scale prospective studies are required to validate these results. 
 
Panteleimonitis S, Ahmed J, Harper M, Parvaiz A. Critical analysis of the literature 
investigating urogenital function preservation following robotic rectal cancer 
surgery. World J Gastrointest Surg 2016; In press 
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INTRODUCTION  
Colorectal cancer is one of the most common cancers in the developed world[1–3] 
with rectal cancers making up a third of those cancers[2–4]. The aim of rectal cancer 
surgery is to radically resect the cancer in order to achieve oncological cure and 
avoid local recurrence. During the past three decades significant improvements have 
been made to combat this predicament. These advances include earlier diagnosis, 
advanced surgical techniques and the improvement of adjuvant and neoadjuvant 
treatment[4–8]. These developments were not only aimed to improve the patients’ 
survival but also directed to improve the quality of life after cancer rectal surgery.  
Urogenital function is one of the most important aspects of quality of life and 
rectal cancer may have adverse effects on it[5,9–13]. Although urogenital dysfunction is 
considered to be multifactorial, intra-operative damage to the pelvic autonomic 
nerves is the primary cause[14–16]. This is mainly due to the close proximity of the 
mesorectum to the autonomic nerves, and the difficulty in identifying such small 
structures such as the autonomic nerves in a narrow operative space such as the 
pelvis[13,17]. Damage to the sympathetic nerves results in urinary incontinence, 
ejaculation disorders in men and decreased orgasmic intensity in women[13,18]. 
Damage to the parasympathetic nerves leads to a lack of detrusor muscle function 
and subsequent voiding disorder, as well as erectile problems and lubrication 
dysfunction in men and women respectively[13,18]. These are significant post-
operative and life changing events that jeopardise patients quality of life[9].  
It is logical to assume that better visualisation of the structures of the pelvis, such 
as offered from laparoscopic or robotic surgery, can aid preservation of the 
autonomic nerves. Nevertheless, there is a debate as to whether laparoscopic surgery 
offers improved urogenital functional outcomes when compared to open surgery[19], 
as some studies have shown improved outcomes[20] while other advocate the 
contrary[21]. A probable reason for the disparate results is due to laparoscopic rectal 
surgery being technically difficult[22], as evident from its long learning curve[23] and 
the high conversion rate demonstrated in the CLASSICC and COLOR II trials[24,25]. 
Existing laparoscopic instruments have a restricted range of movement compared 
with that of the surgeons hand and are difficult to use in confined spaces such as the 
pelvis[26,27].  
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Robotic surgical systems were introduced to overcome the technical limitations of 
laparoscopic surgery[28]. They provide a superior three dimensional view, tremor 
filtering and superior ergonomic instrumentation[26,29]. These chattels enable precise 
dissection in narrow surgical fields such as the pelvis and help preserve the 
autonomic nerves. Even though multiple studies have examined the pathological, 
oncological and postoperative outcomes of robotic rectal surgery, there are only a 
few studies that have investigated the urological and sexual outcomes of robotic 
rectal cancer surgery and these tend to be predominantly about male patients.  
Therefore the aim of this systematic review is to examine the available literature 
on the postoperative urogenital outcomes of robotic rectal cancer surgery on both 
male and female patients.  
 
MATERIALS AND METHODS 
A comprehensive literature search of electronic databases was performed in October 
2015 by using the Discovery search engine tool (for more info refer to: 
http://www.port.ac.uk/library/infores/discovery/). Discovery is Portsmouth 
University’s search engine tool and it simultaneously searches over 200 scientific 
electronic databases including MEDLINE (PubMed), Google Scholar and Science 
Direct. The following search terms were applied: “rectal cancer” OR “colorectal 
cancer” AND robot* OR “da Vinci” AND sexual OR urolog* OR urinary OR erect* 
OR ejaculat* OR impot* OR incontinence. All original studies that reported the 
urological and/or sexual outcomes of patients having robotic rectal cancer surgery 
were included. Reference lists of all retrieved articles were manually searched for 
further relevant articles. A flow diagram of the selection process is given in Figure 1. 
Abstracts were independently searched by two authors. Fifteen full text articles 
fulfilled the inclusion criteria.  
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RESULTS 
Original studies 
A total of 1338 patients were included in the reviewed studies (818 received robotic, 
498 laparoscopic and 22 open rectal cancer surgery). The characteristics of all the 
original studies reporting either urinary or sexual outcomes are outlined in Tables 1 
and 2. Of the 15 studies that met the inclusion criteria, 14 were cohort studies[5,6,9,18,30–
39] and one a randomised control trial[40]. Nine of the cohort studies were comparing 
robotic rectal cancer surgery to either laparoscopic[9,30–33,35,38,40] or open[18] rectal 
cancer surgery.  
Out of the 15 studies only six[5,6,9,18,30,31] were specific to urogenital outcomes; the 
rest reported urogenital outcomes amongst a multitude of outcomes examined in 
those studies.  
 
Outcome assessment 
Functional questionnaire scores were used in ten[5,6,9,18,30–33,36,37] of these studies to 
access the urological and sexual function of patients. These questionnaires are 
validated tools that have been used in a multitude of previous studies to access 
urinary and sexual function in males and females[41–45]. Out of the 1338 patients 
included in this review, only 726 (54%; 442 robotic, 262 laparoscopic, 22 open) had 
their urogenital function assessed via functional questionnaires. 
To assess male urological function the majority of studies used the International 
Prostatic Symptoms Score (IPSS) or a slight modification of it. This is a subjective 
scoring system examining seven categories[41]. These include incomplete bladder 
emptying, frequency, intermittency, urgency, weak stream, straining and nocturia. 
Patients score each category and assign a higher score for increasing severity of 
symptoms. Alternative questionnaires used to assess urological function were the 
the International Consultation on Incontinence Questionnaire - Male Lower Urinary 
Tract Symptoms[44] (ICIQ-MLUTS), and the International Consultation on 
Incontinence Questionnaire - Female Lower Urinary Tract Symptoms[45] (ICIQ-
FLUTS) questionnaire.  
Male sexual function was assessed in ten studies by the International Index of 
Erectile Function (IIEF)[42] score. The IIEF is a 15-item score that analyses five factors: 
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erectile function, orgasmic function, libido, intercourse satisfaction and overall 
satisfaction. Unlike the IPSS score for urinary function, a high IIEF score is associated 
with good sexual function and the lower the IIEF score the greater the degree of 
sexual dysfunction. 
Female sexual function was assessed in three studies[6,30,37] via the Female Sexual 
Function Index (FSFI)[43]. This is a validated questionnaire that is in many ways the 
female version of the IIEF questionnaire.  
The studies that did not use validated scoring tools to assess functional outcomes 
simply reported the incidence of dysfunction. The limitations present in this method 
of reporting are the inability to quantify dysfunction and the difficulty in defining 
what makes a case. 
Finally, one study[31] assessed urological function by performing urodynamic 
studies as well as using a validated functional questionnaire, making it the only 
study to report urinary outcomes with both subjective and objective measurement 
tools. 
 
Pre-operative assessment and follow up 
The studies assessing functional outcomes via validated questionnaires asked their 
participants to fill the questionnaires pre-operatively in order to establish their 
baseline urogenital function. In this way post-operative scores were assessed against 
the pre-operative scores for each patient, allowing the change of function from 
baseline to be assessed. Reporting the change of function from baseline is a more 
accurate way of assessing the impact of the intervention, rather than reporting the 
postoperative functional scores alone. 
It was unclear across several of the studies[6,18,30,32] how many patients were 
sexually inactive pre-operatively and whether they were included in the analysis. 
Adding sexually inactive patients in the analysis will result in skewing of the data 
and it is therefore important to report how many patients were sexually inactive and 
whether they were included in the analysis or not. 
In contrast to the studies applying validated functional scores, most of the studies 
that simply reported the incidence of urogenital dysfunction did not mention the 
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pre-operative state of their participants. This makes it difficult to assess whether any 
cases of dysfunction became cases because of the intervention or not. 
Follow up was fairly variable between the different studies and the follow up 
intervals for each study are summarised in Table 2. The majority of the studies 
followed up their patients in more than one occasion following surgery. The 
commonest follow up intervals were 3, 6 and 12 mo post-operatively.  
 
Quality of included original studies 
The Scottish Intercollegiate Guidelines Network (SIGN) critical appraisal tool for 
cohort studies was used to evaluate the original studies included in this review. 
However, none of the studies met the majority of the criteria for a high quality 
study. Most of the studies fell between the acceptable and low quality bracket (Table 
2). The majority of studies were retrospective in nature, included a small number of 
patients, were subject to selection bias in terms of patient selection and made no 
adjustments for confounding factors.  
The studies included in this review have significant differences in terms of 
outcome reporting and methodology. In addition, almost all of them are non-
randomised in nature. Considering this and because of the heterogeneity of the data 
in these studies it was not appropriate to perform a meta-analysis. There are only a 
few studies whose data were homogeneous enough to permit a meta-analysis. 
However, this has already been performed by two previous systematic reviews[46,47] 
which combined the data of three studies. We discuss these systematic reviews in 
our discussion. 
 
Male urological function 
Out of the 15 original studies included, 12 studies reported male urological 
functional outcomes. The characteristics of these studies plus a summary of their 
results are present in Table 3.  
Validated functional scores were used in nine of the above studies. Six of those 
compared the scores of patients undergoing robotic surgery with those undergoing 
laparoscopic or open surgery. Most studies[18,30,32,33] showed that urological function 
tended to deteriorate in the early postoperative phase (1-3 mo) but later recovered 
10	  
	  
with time (6-12 mo) irrespective of surgical modality. One study[9] found that IPSS 
score change from baseline was less in the robotic group at 12 mo after surgery, but 
failed to reach statistical significance (P = 0.051).  
Kim et al[31] reported IPSS scores in favour of the robotic group. They found that 
IPSS scores significantly increased 1 mo after surgery; but then recovered in 3 mo in 
the robotic group and 6 mo in the laparoscopic group with a statistically significant 
lesser deterioration of scores from baseline in the 3 mo follow up period in the 
robotic group (P = 0.036). It is worth noting that Kim et al’s[31] study was the only one 
to assess urinary function by means of urodynamic studies in conjunction with a 
functional score. He reported that the deterioration in mean voiding volume from 
baseline was statistically less in 3 and 6 mo post-op in favour of the robotic group (P 
= 0.007, P = 0.049). The only other study to report urological outcomes in favour of 
the robotic group was Cho et al’s[35] study; reporting a higher voiding dysfunction 
rate in the laparoscopic group (4.3% vs 0.7%; P = 0.012). However, this study did not 
use any functional scores to assess urological function. 
 
Female urological function 
Seven studies reported female urological functional outcomes (Table 4). However, 
there are only two studies that report female urological dysfunction independently 
to that of males.  
Both studies used approved functional scores to assess urinary function and both 
studies compared robotic surgery patients with laparoscopic surgery patients. 
Morelli et al[30] found no difference between the pre-operative and post-operative 
scores concerning voiding and filling symptoms in both groups. Conversely, Luca et 
al[6] reported worsening of symptoms one month post operatively with full recovery 
by 12 mo in both robotic and laparoscopic groups.  
 
Male sexual function 
Fourteen original studies reported male sexual functional outcomes (Table 5). Ten of 
those assessed male sexual function via the IIEF[42] questionnaire.  
Six of the ten studies using the IIEF scores compared the scores of patients 
receiving robotic rectal cancer surgery with that of a control. Park et al’s[9] study 
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showed that sexual function recovers faster in the robotic group. At 6 mos the IIEF 
scores in the robotic group were higher than in the laparoscopic group and showed a 
significantly smaller decrease from baseline (P = 0.03). Kim et al[31] also found that 
sexual function recovered quicker in the robotic group (6 mo vs 12 mo), but unlike 
Park et al’s[9] study, when comparing the change of total IIEF scores from baseline no 
significant difference was detected. However, erectile function and libido had 
deteriorated significantly more in the laparoscopic group 3 mo post op. Park et al[32] 
showed similar results, with significantly higher mean IIEF scores at 3 and 6 mo post 
op in favour of the robotic group. Like Kim et al’s[31] study, the change of scores from 
baseline did not statistically favour either intervention. In Morelli et al’s[30] study 
erectile and orgasmic function was significantly worse 1 mo after RobTME while it 
was significantly worse after 1 and 6 mo after LapTME, with erectile and orgasmic 
function normal at 12 mon in both groups. The other components of the IIEF score 
deteriorated 1 and 6 mo following surgery in both groups, with normalisation of the 
scores at 12 mo. D’Annibale et al[33] reported better restoration of erectile function 1 
year after surgery in the robotic group; however, there is no mention of the actual 
IIEF scores or their change from baseline in the study so any results need to be 
interpreted with caution. Overall, the above comparative studies seem to report a 
trend towards quicker recovery of sexual function in the robotic group. However, 
Park et al’s[9] study was the only one to reveal an interval change in IIEF scores in 
favour of the robotic group that was statistically significant. 
 
Female sexual function 
In contrast to male sexual function, only a few studies have investigated sexual 
function in females (Table 6). Only three studies have examined female sexual 
dysfunction independently with that of males[6,30,37] and only one of those compared 
robotic outcomes to those of a control group[30]. All three studies assessed female 
sexual function via the FSFI.  
Morelli et al[30] reported worsening of sexual outcomes in both groups 1 and 6 mo 
following surgery, but sexual outcomes were restored by 12 mo. There were no 
differences between the robotic and laparoscopic groups. Luca et al[6] demonstrated 
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similar results in their robotic group as in Morelli et al’s[30] study, whereas Stanciulea 
et al[37] reported no difference between pre- and post-operative FSFI scores.  
 
DISCUSSION 
This literature review highlights the fact that the impact of robotic rectal surgery on 
urogenital functional outcomes is yet to be established. There are number of 
limitations in the current studies. These include poor study design, small number of 
participants, lack of stringent follow up and limitations to the methods and types of 
data collected. 
The main limitations of the primary studies were the lack of randomisation, 
retrospective design and small number of cases in the majority of studies (Tables 1 
and 2). As for the prospective studies, most of them failed to mention the number of 
patients excluded during recruitment, the number of patients refusing to participate 
and the number of drop outs. There was one RCT but randomisation was abandoned 
early on as the operating surgeon quickly favoured the robotic approach for low 
rectal tumours. In terms of participant selection only nine studies reported their 
outcomes against those of a control, with the other studies essentially only 
describing their case series rather than comparing them to alternative treatment 
methods.  
Case matching was performed in 2 of the comparative studies[9,35], but in the 
remaining studies patient selection was susceptible to selection bias due to the 
method of patient selection and allocation. In a number of studies patients were only 
able to receive robotic surgery if they covered the extra costs themselves, leaving the 
patients that couldn’t afford it opting for laparoscopic or open surgery instead. 
Therefore the validity of the data may be skewed since patients that opted for robotic 
surgery were more likely to be from a higher socio-economic background, which is a 
potential confounding factor. Moreover, two studies compared their robotic cases 
with an equivalent number of their first laparoscopic cases[30,33]. This selection 
method was done to eliminate the confounding factor of a learning curve from either 
method. However, the learning curve for each method is not equal[48] and since in 
both studies all cases were performed by one surgeon only, it is possible that many 
of the skills acquired from the laparoscopic method were transferable to the robotic 
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one. This way, results in favour of the robotic group could simply represent 
advancement in the surgeon’s operative technique rather than superiority for the 
robot. 
Patients in the robotic cohort either had a fully robotic procedure or a hybrid 
procedure (Table 2). The main difference between the two approaches is that in the 
hybrid approach robotic rectal dissection is preceded by laparoscopic mobilisation of 
the left colon and ligation of the inferior mesenteric vessels. It is possible that the 
difference in approach could influence urogenital outcomes. Supporters of the fully 
robotic approach would advocate that robotic dissection around the inferior 
mesenteric artery pedicle is an essential step of the procedure for identification and 
preservation of the periaortic nerves[49], which is where the superior hypogastric 
plexus lies. Moreover, the paired hypogastric nerves are susceptible to injury during 
mobilisation of the rectosigmoid colon from the gonadals and the ureter[13]; a step 
performed laparoscopically during the hybrid approach. Since injury to those nerves 
can lead to urogenital dysfunction, the hybrid approach might not exploit the full 
potential of the robotic system.  
Five studies did not use functional scores to assess urogenital outcomes. The 
challenge with only reporting the incidence of urological or sexual dysfunction is not 
only the inability to quantify the level of dysfunction but also to define what makes a 
case. Furthermore, where studies fail to report how many of the patients were 
sexually active pre-operatively, observational bias may be present.  
It is important to mention that even though iatrogenic nerve injury is the primary 
cause of urogenital dysfunction[14–16], this group of symptoms is probably 
multifactorial in origin. Ozeki et al[18] utilised univariate analysis and found that age 
and post-operative complications significantly affected urinary function and sexual 
function respectively at 12 mo follow up. Sexual function in comparison to 
urological function is reported as being influenced by psychological factors and this 
is the case more so in women[4,6]. Luca et al[6] showed that whereas the presence of an 
ileostomy in men did not influence sexual function, it deeply affected it in women. 
Furthermore, poor body image, fatigue, depression, loss of independence and 
changes in relationships have all been identified as important factors in women’s 
sexual dysfunction[4]. In addition, radiation induced ovarian failure in 
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premenopausal women can further worsen sexual symptoms[4]. Since the above are 
potentially important confounding factors, it is important for the control group to be 
as similar to the experimental group as possible or control for these confounders in 
the analysis, something absent in the studies examined in this review. 
In this review we did not perform a meta-analysis due to the heterogeneity of the 
included studies. Nevertheless, it should be mentioned that two review articles have 
performed meta-analyses on male urological and sexual function scores of patients 
receiving robotic vs laparoscopic rectal surgery[46,47]. For male urological function, 
the reviews pooled the data from three studies and found that at 3 mo there was a 
significant difference of IPSS scores in favour of the robotic group. However, this 
was not the case at 6 mo following surgery and at 12 mo the two meta-analyses 
reported contradictory results, one showing favourable IPSS scores for the robotic 
group[46] whilst the other demonstrated no difference between the two groups[47]. 
Regarding male sexual function, the meta-analyses pooled the data for erectile 
function only. By including three and two studies respectively[46,47], both reviews 
demonstrated favourable erectile function scores for the robotic group at 3 and 6 mo 
following surgery. Weighing these results one should note that as a rule, the overall 
quality of a meta-analysis is limited to the quality of its primary studies, and since 
the quality of the evidence available is low, the results of the available meta-analysis 
are of equally low quality. 
There is a degree of inconsistency of results across the research examined in this 
review and the potential for bias amongst the various studies on the subject. There is 
a lack of high level evidence supporting any particular approach for preservation of 
urogenital function following rectal surgery. Nevertheless, the current evidence 
suggests that robotic surgery might lead to a quicker recovery of male urological and 
sexual function when compared to alternative methods. It is less clear whether 
robotic surgery makes any difference in male urogenital outcomes 1 year following 
surgery. In females the evidence on urogenital function following robotic rectal 
surgery is further limited. Again functional outcomes seem to improve with time but 
this is regardless of operative approach.  
Larger randomised controlled trials such as the ROLARR trial[50] might provide 
more insight into this matter. However, even though the ROLARR trial is underway, 
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urogenital outcomes are not one of its primary ends points and urogenital outcomes 
are only assessed once following surgery, at six months. Therefore, to answer 
whether robotic rectal cancer surgery truly offers superior urogenital outcomes 
further randomised control trials specifically designed to evaluate urogenital 
function with appropriate short and long term follow up are recommended. In 
addition, urogenital dysfunction should be rigorously assessed through appropriate 
validated functional scores and males should be analysed separately to females.  
 
COMMENTS 
Background 
Urological and sexual dysfunctions are unfortunate sequela of rectal cancer surgery. 
They occur due to iatrogenic injury to the pelvic autonomic nerves during the 
surgical process and cause significant quality of life limitations for patients. Better 
visualisation of the pelvis such as during laparoscopy has failed to address this issue 
due to the stiff, fixed tip instruments used for laparoscopy being hard to use in 
narrow spaces such as the pelvis. Robotic surgical systems overcome many of the 
limitations of laparoscopic surgery but whether robotic rectal surgery can lead to 
superior urological and sexual functional outcomes remains to be determined. 
 
Research frontiers 
Robotic surgical systems possess several advantages over conventional laparoscopy 
such as flexible wristed instruments that mimic the surgeon’s hands. They eliminate 
the surgeon’s tremor and offer far superior ergonomics and dexterity. In addition, 
the surgeon, rather than the assistant, controls a 3-D, high definition stable camera, 
an important aspect for co-ordinated surgery. These advantages allow for precision 
surgery in narrow spaces such as the pelvis, where other methods have failed and in 
rectal surgery could enable preservation of the pelvic autonomic nerves and 
therefore increase the quality of life for these patients. 
 
Innovations and breakthroughs 
There are only a few studies that have investigated the urological and sexual 
outcomes of robotic rectal surgery and these tend to be predominantly about male 
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patients. This study differs by critically reviewing the available literature on the 
postoperative urological and sexual outcomes of robotic rectal surgery on both male 
and female patients. As such, this review is unique in that it examines the largest 
number or relevant studies to date; it focuses solely on the urogenital outcomes of 
robotic rectal surgery and examines the evidence on both males and females. 
 
Applications 
This review critically analyses the literature examining the urogenital outcomes of 
robotic rectal cancer surgery. Readers will be able to have a concise understanding of 
the available literature on this subject. Furthermore, this review leads to clear 
conclusions indicating a paucity of evidence of whether robotic rectal surgery offers 
favourable urogenital functional outcomes and establishes quality of life differences. 
Nevertheless, the authors identify that robotic surgery might lead to a quicker 
recovery of male urological and sexual function when compared to alternative 
methods of surgery and recommend the direction of further research.  
 
Terminology 
Urogenital function is a term referring to the combination of urological and sexual 
function. Laparoscopic and robotic surgeries are forms of minimally invasive 
surgery which offer several advantages over open surgery, such as smaller wounds 
and quicker postoperative recovery. 
 
Peer-review 
The manuscript is a comprehensive review addressing pelvic functions (rectal and 
sexual) after robotic surgery. Content coverage is adequate and focus. Language 
quality and flow of idea are excellent. 
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These include: (1) the studies country of origin; (2) the study design (prospective, 
retrospective or randomised control trial); (3) the control group (if present) used to 
Ref. 
Country 
 
Study design 
Control group 
 
No. of cases for urogenital outcomes 
Study 
specifically 
examines 
urogenital 
outcomes 
Hellan et al[34]  
United 
States Retrospective No control group 39 No 
Patriti et al[40] Italy RCT Robot  vs  lap 29 rob  vs  37 lap No 
Luca et al[6] Italy Prospective No control group 74 Yes 
Kim et al[31] 
South 
Korea Prospective Robot  vs  lap 30 rob  vs  39 lap Yes 
Park et al[39] 
United 
States Prospective No control group 30 No 
Leung et al[5] 
Hong 
Kong Prospective No control group 33 Yes 
Park et al[32] 
South 
Korea Retrospective Robot  vs  lap 14 rob  vs  15 lap No 
D'Annibale et 
al[33] Italy Retrospective Robot   vs lap 30  vs  30 No 
Stanciulea et al[37] Romania Retrospective No control group 78 No 
Erguner et al[38] Turkey Prospective Robot  vs  lap 27 rob  vs  37 lap No 
Park et al[9] 
South 
Korea Retrospective Robot  vs  lap 32  vs  32 Yes 
Ozeki et al[18] Japan Prospective Robot  vs  open 15 rob  vs  22 open Yes 
Cho et al[35] 
South 
Korea Retrospective Robot  vs  lap 278  vs  278 No 
Alecu et al[36] Romania Retrospective No control group 79 No 
Morelli et al[30] Italy Retrospective Robot  vs  lap 30  vs  30 Yes 
25	  
	  
compare with the robotic rectal surgery, this was either laparoscopic or open rectal 
surgery cases; (4) the number of cases included in each study whose urogenital 
outcomes were evaluated; and (5) whether the study was specifically designed to 
investigate the urogenital outcomes of robotic surgery or not. RCT: Randomised 
control trial; Robot: Robotic; lap: Laparoscopic. 
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Table 2 Further characteristics of original studies 
Ref. 
Fully or 
Hybrid 
robotic 
procedure 
Functional 
scores 
applied 
Follow up in months 
No. of surgeons 
performing cases  
SIGN score 
Hellan et al[34]  Hybrid No Median f/u 13 mo Not stated + 
Patriti et al[40] Hybrid No Mean f/u 12 mo Not stated + 
Luca et al[6] Fully Yes 1, 6, 12 2 surgeons ++ 
Kim et al[31] Hybrid Yes 1, 3, 6, 12 1 surgeon ++ 
Park et al[39] 
Reverse 
hybrid No Not stated Not stated + 
Leung et al[5] Mixture Yes 3 Not stated ++ 
Park et al[32] Hybrid Yes 3, 6, 12 1 surgeon ++ 
D'Annibale et al[33] Fully Yes 1, 12 1 surgeon ++ 
Stanciulea et al[37] 93% fully Yes Once b/n 6 and 12 mo 3 surgeons + 
Erguner et al[38] Mixture 
 
Not stated Not stated + 
Park et al[9] Hybrid Yes 3, 6, 12 1 surgeon ++ 
Ozeki et al[18] Fully Yes 3, 6, 12 2 for robot cases ++ 
Cho et al[35] Fully No 1 
3 surgeons did 97.1% 
cases ++ 
Alecu et al[36] Hybrid Yes Not stated Not stated + 
Morelli et al[30] Not stated Yes 1, 6, 12 1 surgeon ++ 
These include: (1) whether the surgeons used the hybrid or robotic approach for 
their study; (2) whether urogenital function was assessed by means of functional 
scores or not; (3) the follow up period during which data for urogenital outcomes 
was collected; (4) the number of surgeons performing the cases in each study; and (5) 
the studies SIGN score. f/u: Follow up; SIGN: Scottish Intercollegiate Guidelines 
Network. 
 
Table 3 Original studies reporting male urological function 
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Ref. 
Males 
assessed 
independently 
of females  
Functional 
scores 
applied 
Control 
group 
  
No. of 
cases 
examining 
male 
urological 
function 
Follow 
up in 
months 
Outcome summary 
Kim et al[31] No Yes 
Robot vs 
lap 
30 rob vs 
39 lap 
1, 3, 6, 
12 
Urological function recovered faster in robotic 
group (3 mo vs 6 mo). 
IPSS change from baseline lower in robotic group 
at 3 mo (P = 0.036) 
Mean voiding volume deterioration lower in 3 
and 6 mo in robotic group (P =0.007, P =0.049) 
Similar outcomes at 12 mo in both groups  
Park et al[9] 
Yes Yes 
Robot vs 
lap 32 vs 32 3, 6, 12 
IPSS scores elevated post-operatively in both 
groups 
At 12 mo IPSS change from baseline lower in 
robotic group but non- significant (P =0.051) 
Park et al[32] 
Yes Yes 
Robot vs 
lap 
14 rob vs 
15 lap 3, 6, 12 
Deterioration of IPSS scores in 3 mo which 
recovered by 6 mo in both groups 
D'Annibale 
et al[33] Yes Yes 
Robot vs 
lap 30 vs 30 1, 12 
Deterioration of IPSS scores in 3 mo which 
recovered by 12 mo in both groups 
Ozeki et 
al[18] Yes Yes 
Robot vs 
open 
15 rob vs 
22 open 3, 6, 12 
No statistical deterioration of IPSS scores in either 
group 
Morelli et 
al[30] 
Yes Yes 
Robot vs 
lap 
not 
available 1, 6, 12 
Voiding and incontinence worse 1 mo in both 
groups, incontinence recovered by 6-12 mo in both 
groups 
Leung et al[5] 
Yes Yes 
No 
control 
group 33 3 
No significant male urological function 
deterioration 
Luca et al[6] 
Yes Yes 
No 
control 38 1, 6, 12 
No significant male urological function 
deterioration 
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group 
Stanciulea et 
al[37] 
No Yes 
No 
control 
group 78 
Once 
b/n 6 
and 12  
No deterioration in IPSS scores but no data 
presentation in results 
Hellan et 
al[34] 
No No 
No 
control 
group 39 
median 
F/U 13 
mo 
One patient (2.56%) developed bladder 
dysfunction post operatively 
Park et al[39] 
No No 
No 
control 
group 30 
Not 
stated 
No patients developed bladder dysfunction post 
operatively 
Cho et al[35] 
No No 
Robot vs 
lap 278 vs 278 1 
Voiding dysfunction rate higher in the 
laparoscopic group (4.3% lap vs 0.7% rob; P = 
0.012) 
The following study characteristics are described: (1) whether male patients were 
assessed independently of female patients or not, in studies that this was not the case 
data from male and female patients was combined; (2) whether functional scores 
were used to assess urogenital outcomes or not; (3) the control group used in the 
study if applicable; (4) the number of cases examining male urological function; (4) 
the follow up periods in months; and (5) a brief summary of the study’s findings 
regarding male urological function. Robot: Robotic; lap: Laparoscopic; f/u: Follow 
up; IPSS: International Prostatic Symptoms Score. 
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Table 4 Original studies reporting female urological function  
Ref.  
Females 
assessed 
independently 
of males  
Functional 
scores 
applied 
Control 
group 
  
No. of 
cases 
examining 
female 
urological 
function 
  
Follow 
up in 
months 
Outcome summary 
  
Morelli et 
al[30] Yes Yes 
Robot vs 
lap 
not 
available 1, 6, 12 
No difference between the pre- and post- operative 
scores in both groups 
Luca et 
al[6] 
Yes Yes 
No 
control 
group 36 1, 6, 12 
Worse female urological function at 1 mo with full 
recovery by 12 mo in both groups 
Kim et 
al[31] No Yes 
Robot vs 
lap 
30rob vs 
39lap  
1, 3, 6, 
12 
 As in table 3 
Stanciule
a et al[37] 
No Yes 
No 
control 
group 78 
once 
b/n 6 
and 12 
 As in table 3 
Hellan et 
al[34] 
No No 
No 
control 
group 39 
median 
f/u 13 
mo 
 As in table 3 
Park et 
al[39] 
No No 
No 
control 
group 30 
not 
stated 
 As in table 3 
Cho et 
al[35] No No 
Robot vs 
lap 278 vs 278 1 
 As in table 3 
This table describes the same study characteristics included in table 3 but for female 
instead of male patients. Robot: Robotic; lap: Laparoscopic; f/u: Follow up. 
 
Table 5 Original studies reporting male sexual function  
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Study  
Males 
assessed 
independently 
of females  
Functional 
scores 
applied 
Control 
group 
  
No. of 
cases 
examining 
male 
sexual 
function 
  
Follow 
up in 
months 
Outcome summary 
  
Kim et 
al[31] 
Yes Yes 
Robot vs 
lap 
18 rob vs 
20 lap 
1, 3, 6, 
12 
Quicker recovery of male sexual function in robotic 
group (6 mo vs 12 mo) 
No difference in IIEF change from baseline between 
two groups at any stage  
Erectile function and libido deteriorated significantly 
more in lap group at 3 mo  
Park et 
al[9] 
Yes Yes 
Robot vs 
lap 20 vs 20 3, 6, 12 
Quicker recovery of male sexual function in robotic 
group (6 mo vs 12 mo) 
IIEF deterioration significantly higher in lap group at 6 
mo (p=0.03) 
Park et 
al[32] 
Yes Yes 
Robot vs 
lap 
14 rob vs 
15 lap 3, 6, 12 
Better male sexual function scores at 3 and 6 mo in 
robotic group 
No difference in IIEF change from baseline between 
two groups at any stage  
D'Anni
bale et 
al[33] 
Yes Yes 
Robot vs 
lap 
18 rob vs 
23 lap 1, 12 
Erectile function restored 1 year post-operatively in 
robotic group (P = 0.066) and partially in lap group (P 
= 0.048). 
No statistical comparison of IIEF change from baseline 
b/n 2 groups at any stage  
Ozeki 
et al[18] Yes Yes 
Robot vs 
open 
15 rob vs 
22 open 3, 6, 12 
IIEF scores unchanged at 3, 6 and 12 mo in both groups 
Morelli 
et al[30] 
Yes Yes 
Robot vs 
lap 
Not 
available 1, 6, 12 
Quicker recovery of erectile and orgasmic function in 
robotic group (6 mo vs 12 mo) 
No difference in IIEF change from baseline between 
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two groups at any stage  
Leung 
et al[5] 
Yes Yes 
No 
control 
group 
 15 3 
No significant difference between post- and pre-
operative IIEF scores 
Luca et 
al[6] 
Yes Yes 
No 
control 
group 38 1, 6, 12 
Male sexual function scores decreased at 1 and 6 mo, 
recovered at 12 mo 
Stanciu
lea et 
al[37] Yes Yes 
No 
control 
group 31 
once 
b/n 6 
and 12 
No difference of pre- and post-op IIEF scores with 
exception of 3 patients (9.68%) with severe erectile 
dysfunction 
Alecu 
et al[36] 
No Yes 
No 
control 
group 79 
Not 
stated 
3 patients (3.79%) developed important sexual 
dysfunction. No mention of IIEF scores in results 
Patriti 
et al[40] 
Yes No 
Robot vs 
lap 
11 rob vs 
12 lap 
Mean 
f/u 12 
mo 
No difference in the incidence of sexual dysfunction 
between the 2 groups 
Ergune
r et 
al[38] No No 
Robot vs 
lap 
27 rob vs 
37 lap 
Not 
stated 
No difference in the incidence of sexual dysfunction 
between the 2 groups 
Cho et 
al[35] No No 
Robot vs 
lap 278 vs 278 1 
No difference in the incidence of sexual dysfunction 
between the 2 groups 
Park et 
al[39] 
Yes No 
No 
control 
group 16 
Not 
stated 
1 patient (6.25%) developed ejaculatory dysfunction, 
no patients developed erectile dysfunction 
This table describes the same study characteristics included in Tables 3 and 4 but for 
studies assessing male sexual function. Robot: Robotic; lap: Laparoscopic; f/u: 
Follow up; IIEF: International Index of Erectile Function score. 
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Table 6 Original studies reporting female sexual function 
Ref. 
Females 
assessed 
independently 
of males  
Functional 
scores 
applied 
Control 
group 
  
No. of 
cases 
examining 
female 
sexual 
function 
  
Follow 
up in 
months 
Outcome summary 
  
Morelli et 
al[30] Yes Yes 
Robot vs 
lap 
not 
available 1, 6, 12 
Female sexual function worse at 1 and 6 mo and 
restored by 12 mo, in both groups 
Luca et al[6] Yes Yes 
No 
control 
group 36 1, 6, 12 
Female sexual function worse at 1 and 6 mo and 
restored by 12 mo 
Stanciulea 
et al[37] Yes Yes 
No 
control 
group 13 
Once 
b/n 6 
and 12 
No difference between pre- and post-operative 
FSFI scores (but data not provided in results 
section) 
Alecu et 
al[36] No Yes 
No 
control 
group 79 pts 
Not 
stated 
 As in Table 6 
Erguner et 
al[38] No No 
Robot vs 
lap 
27 rob vs 
37 lap 
Not 
stated 
 As in Table 6 
Cho et al[35] No No 
Robot vs 
lap 278 vs 278 1 
 As in Table 6 
This table describes the same study characteristics included in Tables 3, 4 and 5 but 
for studies assessing female sexual function. Robot: Robotic; lap: Laparoscopic; FSFI: 
Female Sexual Function Index. 
 
